Daniel Lee Flynn, Chief Scientific Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 4,806 shares at $21.24 ($102K) on 2023-01-17, disclosed to the SEC on 2023-01-19.
Open-market sale of $102k DCPH by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.24 | 2,403 | $51K | 50.0% |
| 2 | $21.24 | 2,403 | $51K | 50.0% |
| Total | $21.24 avg | 4,806 | $102K | 100% |
| Filing → |
| DCPH | SELL | 2022-06-21 | $19K | — | Filing → |
| DCPH | SELL | 2022-02-18 | $12K | — | Filing → |
| DCPH | SELL | 2021-02-18 | $25K | — | Filing → |